No Data
No Data
Is Daan Gene (SZSE:002030) Using Debt Sensibly?
Daan Gene's Unit Gets Registration Certificate for Alpha-Fetoprotein Kit
daan gene co.,ltd. (002030.SZ) subsidiary has obtained a registration certificate for a medical instrument.
daan gene co.,ltd. (002030.SZ) announced that its wholly-owned subsidiary Guangzhou Datai Biotechnology Engineering Technology Co., Ltd...
daan gene co.,ltd. (002030.SZ): The wholly-owned subsidiary received a cash dividend of 0.4634 million yuan.
On September 26, Gelonhui announced that daan gene co.,ltd. (002030.SZ) disclosed that its wholly-owned subsidiary, Guangzhou Daan Gene Technology Co., Ltd. (referred to as 'Daan Technology' below), recently received cash dividends from its invested company, Zhuhai Yasha Biotechnology Co., Ltd. (referred to as 'Yasha Stock'). The specific situation is as follows: According to the resolution of the 2024 third interim shareholders' meeting of Yasha Stock, the profit distribution scheme is: Based on the existing total share capital of 41,927,609 shares, a cash dividend of 1.2 RMB per 10 shares will be distributed to all shareholders. Daan Technology, a wholly-owned subsidiary of the company, holds a stake in Yasha Stock.
Daan Gene (SZSE:002030 Investor Three-year Losses Grow to 68% as the Stock Sheds CN¥407m This Past Week
Daan Gene Co., Ltd. (002030.SZ): Cooperating with an independent medical laboratory to carry out some tumor gene testing projects.
Daan Gene Co.,Ltd. (002030.SZ) stated during investor relations activities that the overall sales volume of the company's products is showing an increasing trend. Tumor detection products such as EB, HPV, etc. have certain sales; in addition, the company collaborates with independent medical laboratories to carry out some tumor gene detection projects.
No Data
No Data